Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 1,6011,620 of 20,252 grants

Active NON-SBIR/STTR RPGS
Noninvasive High-Resolution Mapping of HCC Tumor Biology Predictive of Malignancy
NATIONAL CANCER INSTITUTE University of Illinois At Chicago United States 2024 – 2029

PROJECT ABSTRACT: Hepatocellular carcinoma (HCC) is an aggressive malignancy representing the 7th most common cancer globally and the 4th most common cause of cancer death worldwid...

$6.57M
USD
Active NON-SBIR/STTR RPGS
Use of Noninvasive Biomarkers and Advanced MRI for early detection of NF1-associated MPNSTs
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2029

ABSTRACT Approximately 120,000 Americans with neurofibromatosis type I (NF1) suffer a constellation of clinical manifestations, including aberrant proliferation of neural tissues l...

$6.14M
USD
Active OTHER RESEARCH-RELATED
CAPRI: Columbia Cancer Research Training Program for Resident-Investigators
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2024 – 2029

Project Summary/Abstract This is a proposal to fund an established post-doctoral training program called the Columbia Cancer Research Training Program for Resident-Investigators (C...

$5.38M
USD
Completed NON-SBIR/STTR RPGS
Acupuncture to Improve Outcomes in Patients with Sepsis: a Randomized Controlled Trial
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT: Sepsis is a life-threatening medical condition characterized by high levels of inflammatory markers and multi-organ damage. Despite standard treatment, se...

$2.06M
USD
Active NON-SBIR/STTR RPGS
Understanding Pancreatic Cancer Immune Microenvironment and Treatment Response through Integrating in vivo Imaging with Immunophenotyping
NATIONAL CANCER INSTITUTE University of Louisville United States 2024 – 2029

Project Summary Although cancer immunotherapy has been proclaimed a breakthrough in many types of cancer, pancreatic ductal adenocarcinoma (PDAC) responds poorly to immune checkpoi...

$6.49M
USD
Active NON-SBIR/STTR RPGS
Translational Combinations of Nanocarriers and Blockers for Metastatic Breast Cancer
NATIONAL CANCER INSTITUTE University of Illinois At Urbana-Champai... United States 2024 – 2029

ABSTRACT Metastasis contributes to the vast majority of breast cancer deaths but current therapies for disseminated disease have limited efficacy and significant side effects. Immu...

$5.71M
USD
Completed OTHER RESEARCH-RELATED
Reprogramming T cell function with multiplexed genome engineering to develop next-generation immunotherapy
NATIONAL CANCER INSTITUTE Yale University United States 2024 – 2026

Project Summary: Adoptive cellular immunotherapy utilizing T cells engineered with chimeric antigen receptor (CAR) has shown durable clinical responses in hematologic malignancies....

$1.43M
USD
Active OTHER RESEARCH-RELATED
Training clinicians in the integration of technology with cancer supportive care
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2024 – 2029

PROGRAM SUMMARY Recent epidemiologic evidence highlights the significant unmet behavioral health needs of cancer patients in the United States. A strong evidence base now supports...

$3.14M
USD
Active NON-SBIR/STTR RPGS
Fidelity Mechanisms of DNA Polymerase Beta
NATIONAL CANCER INSTITUTE University of Nebraska Medical Center United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Mutations in the human genome give rise to many human diseases including cancer. Mutations are also beneficial for processes including evolution and adapti...

$6.62M
USD
Active NON-SBIR/STTR RPGS
High Throughput Digital Droplet Assays for Ultrasensitive Multimodal (DNA, RNA, and Protein) Diagnostics
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2024 – 2027

Abstract Digital assays — in which ultra-sensitive molecular measurements are made by performing millions of parallel experiments in picoliter droplets — have generated much recent...

$3.9M
USD
Completed OTHER RESEARCH-RELATED
2024 DNA Damage, Mutation and Cancer Gordon Research Conference and Seminar
NATIONAL CANCER INSTITUTE Gordon Research Conferences United States 2024 – 2025

SUMMARY. The DNA Damage, Mutation and Cancer Gordon Research Conference (GRC) is a leading international scientific conference focused on advancing science through the presentation...

$150K
USD
Completed NON-SBIR/STTR RPGS
Mechanisms of Th17-DC immunotherapy for ovarian cancer
NATIONAL CANCER INSTITUTE University of Arkansas for Med Scis United States 2024 – 2026

The clinical experience with anti-PD-1 immune checkpoint inhibition in ovarian cancer has been disappointing. The poor outcomes may at least in part be due to the highly immunosupp...

$2.15M
USD
Active NON-SBIR/STTR RPGS
Proximity epigenomics for context-specific analysis of complex chromatin features
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2024 – 2027

Project Summary Chromatin context defines all DNA transactions, from gene regulation to genome maintenance. Changes in chromatin composition are hallmarks of cancer cells that cont...

$2.3M
USD
Active NON-SBIR/STTR RPGS
Elucidating The Adaptive Role Of Serine Codons During Pancreatic Tumorigenesis
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2024 – 2029

Pancreatic ductal adenocarincomas (PDAC) is an aggressive disease with poor prognosis and is characterized by a unique microenvironment that is severely depleted of amino acids (AA...

$5.05M
USD
Completed NON-SBIR/STTR RPGS
Discovery and anti-tumor activity of the first antagonists targeting human Sonic Hedgehog autoprocessing
NATIONAL CANCER INSTITUTE State University of Ny,Binghamton United States 2024 – 2026

ABSTRACT We are pursuing the first anti-tumor small molecules that act specifically against human Sonic Hh protein autoprocessing, a unique biosynthetic event that is necessary to...

$1.82M
USD
Completed NON-SBIR/STTR RPGS
Development of immunocompetent melanoma brain metastases organoids
NATIONAL CANCER INSTITUTE University of Arkansas for Med Scis United States 2024 – 2026

Abstract Immune checkpoint inhibition (ICI) can control intracranial disease in approximately 50% of patients with melanoma brain metastases (MBM), which is the leading cause of de...

$765K
USD
Active NON-SBIR/STTR RPGS
Characterizing the sources, mechanisms, and translational relevance of microbial TMAO in driving anti-tumor immunity in pancreatic cancer.
NATIONAL CANCER INSTITUTE Wistar Institute United States 2024 – 2029

PROJECT SUMMARY The treatment of pancreatic ductal adenocarcinoma (PDAC) remains a major hurdle with 5-year survival of 12%. PDAC resistance to chemotherapy and immunotherapy is th...

$5.87M
USD
Active NON-SBIR/STTR RPGS
Elucidating The Adaptive Role Of Serine Codons During Pancreatic Tumorigenesis - Diversity Supplement
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2024 – 2029

Pancreatic ductal adenocarincomas (PDAC) is an aggressive disease with poor prognosis and is characterized by a unique microenvironment that is severely depleted of amino acids (AA...

$790.9K
USD
Active NON-SBIR/STTR RPGS
Tumor Metabolic Profiling by Multiplexed Single-Cell Lipid and mRNA Imaging
NATIONAL CANCER INSTITUTE Stanford University United States 2024 – 2027

Abstract To survive in the nutrient- and oxygen-deprived niche, cancer cells undergo a drastic metabolic reprogramming where they upregulate their endogenous lipid synthesis and ex...

$2.17M
USD
Active NON-SBIR/STTR RPGS
Investigating the Molecular Determinants Driving Response and Resistance to HDAC6 Targeted Therapy in Breast Cancer
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2024 – 2029

SUMMARY We previously reported that the viability of some breast cancers depends on histone deacetylase 6 (HDAC6). We also developed a biomarker (HDAC6-score, validated with a NY C...

$5.86M
USD